学者信息

曾志平 (ZhiPing Zeng)

药学院

ResearcherID:H-6064-2011

合作者

已发表成果:

WOK 论文 41 篇;中文核心 3 篇;

  • SAR study of oxidative DIMs analogs targeting the Nur77-mediated apoptotic pathway of cancer cells

    BIOORGANIC CHEMISTRY,0045-2068,2022-12.
    Chen, Xiaohui; Tu, Xuhuang; Zhang, Xindao; Cao, Bing; Liu, Weirong; Zhang, Jie; Xia, Yongzhen; Bao,...
    WOS:000863346000002   10.1016/j.bioorg.2022.106156
    收录情况:SCIE
  • Design, synthesis and biological evaluation of acyl hydrazones-based derivatives as RXR alpha-targeted anti-mitotic agents

    BIOORGANIC CHEMISTRY,0045-2068,2022-11.
    Wang, Qiqiang; Tu, Xuhuang; Wang, Xin; Cai, Qi; Yu, Liangfa; Zhang, Xuan; Yi, Jiajin; Wu, Yuhang; X...
    WOS:000848488400001   10.1016/j.bioorg.2022.106069
    收录情况:SCIE
  • USP25 inhibition ameliorates Alzheimer's pathology through the regulation of APP processing and A beta generation

    JOURNAL OF CLINICAL INVESTIGATION,0021-9738,2022-03-01.
    Zheng, Qiuyang; Song, Beibei; Li, Guilin; Cai, Fang; Wu, Meiling; Zhao, Yingjun; Jiang, LuLin; Guo,...
    WOS:000764798500005   10.1172/JCI152170
    收录情况:SCIE
  • Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,0006-291X,2022-02-05.
    Chen, Junjie; Zhang, Yaya; Zeng, Dequan; Zhang, Bingchang; Ye, Xiaohong; Zeng, Zhiping; Zhang, Xiao...
    WOS:000768235200004   10.1016/j.bbrc.2021.12.108
    收录情况:SCIE